SEC 13F Intelligence

Cowen Prime Advisors LLC / APYX

Cowen Prime Advisors LLC’s Apyx Medical Corporation Position

Does Cowen Prime Advisors LLC own Apyx Medical Corporation (APYX)? Yes — 605.7K shares worth $3M (+1.05% of its 13F portfolio) as of Q2 2023, up from 602.2K shares the prior filed quarter.

Position Value
$3M
Q2 2023
Shares
605.7K
% of Portfolio
+1.05%
Quarters Held
9
currently held

Position History APYX

Reported value by quarter
Q2 ’21: $3MQ2 ’21Q3 ’21: $3MQ4 ’21: $3MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $1MQ4 ’22: $1MQ4 ’22Q1 ’23: $2MQ2 ’23: $3MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023605.7K$3M+1.05%
Q1 2023602.2K$2M+0.82%
Q4 2022606.3K$1M+0.58%
Q3 2022267.8K$1M+0.69%
Q2 2022267.8K$2M+0.89%
Q1 2022253.9K$2M+0.70%
Q4 2021251.8K$3M+1.10%
Q3 2021251.8K$3M+1.30%
Q2 2021249.0K$3M+0.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cowen Prime Advisors LLC’s full portfolio or all institutional holders of APYX.